In the following video, Motley Fool health-care analyst David Williamson takes investors through what they can expect as Baxter International (BAX 3.66%) reports its quarterly earnings, and he tells us what to look for with this company from here.
Foolish Preview: Baxter Earnings
What to expect from the earnings report from Baxter International.
By Dave Williamson – Jan 23, 2013 at 5:57PM EST
Read Next
About the Author
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Stocks Mentioned
Baxter International
NYSE: BAX
$17.93
(-3.60%)-$0.67
Johnson & Johnson
NYSE: JNJ
$235.85
(-1.58%)-$3.78
Eli Lilly
NYSE: LLY
$976.23
(-0.71%)-$7.03
Fresenius Medical Care
NYSE: FMS
$22.85
(-0.87%)-$0.20
Halozyme Therapeutics
NASDAQ: HALO
$67.75
(+0.58%)+$0.39
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.